就位！医械早知道-8/2

医疗器械创新网2025-08-02

企业投融资与合作方面Orchestra BioMed 获战略投资：Ligand 和美敦力共注入 7000 万美元。其中，Ligand 投资 3500 万美元换取其 AVIM 疗法和 Virtue SAB 未来销售额分级特许权使用费，另在股权私募投资 500 万美元；美敦力在股权私募投资 1000 万美元，另通过可转换为预付收入份额的担保次级本票投资 2000 万美元。双方同时扩大战略合作，推进 ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2556984181?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-08-02 07:00","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2556984181","market":"us","top_or_hot":-1,"title":"就位！医械早知道-8/2","media":"医疗器械创新网","content":"<div>\n<p>企业投融资与合作方面Orchestra BioMed 获战略投资：Ligand 和美敦力共注入 7000 万美元。其中，Ligand 投资 3500 万美元换取其 AVIM 疗法和 Virtue SAB 未来销售额分级特许权使用费，另在股权私募投资 500 万美元；美敦力在股权私募投资 1000 万美元，另通过可转换为预付收入份额的担保次级本票投资 2000 万美元。双方同时扩大战略合作，推进 ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802070608a4706ba0&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>就位！医械早知道-8/2</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n就位！医械早知道-8/2\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-08-02 07:00 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802070608a4706ba0&s=b><strong>医疗器械创新网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>企业投融资与合作方面Orchestra BioMed 获战略投资：Ligand 和美敦力共注入 7000 万美元。其中，Ligand 投资 3500 万美元换取其 AVIM 疗法和 Virtue SAB 未来销售额分级特许权使用费，另在股权私募投资 500 万美元；美敦力在股权私募投资 1000 万美元，另通过可转换为预付收入份额的担保次级本票投资 2000 万美元。双方同时扩大战略合作，推进 ...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802070608a4706ba0&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0820561818.USD","symbol_name":"安联收益及增长平衡基金Cl AM DIS","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802070608a4706ba0&s=b","article_id":"2556984181","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250802070608a4706ba0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2556984181","pubTimestamp":1754089200,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"企业投融资与合作方面Orchestra BioMed 获战略投资：Ligand 和美敦力共注入 7000 万美元。其中，Ligand 投资 3500 万美元换取其 AVIM 疗法和 Virtue SAB 未来销售额分级特许权使用费，另在股权私募投资 500 万美元；美敦力在股权私募投资 1000 万美元，另通过可转换为预付收入份额的担保次级本票投资 2000 万美元。如有平台转载本篇文章，须自行对该篇文章负责，医疗器械创新网不对转载引起的二次传播负责。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0820561818.USD":"安联收益及增长平衡基金Cl AM DIS","LU0708995401.HKD":"FRANKLIN U.S. OPPORTUNITIES \"A\" (HKD) ACC","BK4585":"ETF&股票定投概念","BK4534":"瑞士信贷持仓","DHR":"丹纳赫","LU2125909593.SGD":"Natixis Thematics Meta R/A SGD","LU1791710400.SGD":"Fidelity Global Demographics A-ACC-SGD","LU2106854487.HKD":"ALLIANZ THEMATICA \"AMG\" (HKD) INC","LU1923622614.USD":"Natixis Thematics Meta R/A USD","LU0312595415.SGD":"Schroder ISF Global Climate Change Equity A Acc SGD","LU1023059063.AUD":"BGF WORLD HEALTHSCIENCE \"A2\" (AUDHDG) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","A":"安捷伦科技","LU1551013342.USD":"Allianz Income and Growth Cl AMg2 DIS USD","LU0390134368.USD":"FRANKLIN GLOBAL GROWTH \"A\" (USD) ACC","LU0289739343.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (SGD) ACC","LU0097036916.USD":"贝莱德美国增长A2 USD","LU0689472784.USD":"安联收益及增长基金Cl AM AT Acc","LU0511384066.AUD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"A\" (AUDHDG) ACC","LU0882574055.USD":"富达全球健康医疗A ACC","LU2265009873.SGD":"Eastspring Investments - Global Growth Equity AS SGD-H","LU0107464264.USD":"abrdn SICAV I - GLOBAL INNOVATION EQUITY \"A\" (USD) ACC","SG9999013999.USD":"UOB UNITED GLOBAL HEALTHCARE FUND (USDHDG) INC","LU0289960550.SGD":"AB FCP I - GLOBAL EQUITY BLEND PORTFOLIO 'A' (SGD) ACC","LU1974910355.USD":"Allianz Thematica Cl AMg DIS USD","LU0122379950.USD":"贝莱德世界健康科学A2","SG9999001176.SGD":"UOB UNITED GLOBAL HEALTHCARE \"SGD\" (ACC)","SG9999004303.SGD":"Nikko AM Shenton Global Opportunities SGD","IE0004445239.USD":"JANUS HENDERSON US FORTY \"A2\" (USD) ACC","LU1267930730.SGD":"富兰克林美国机遇基金AS Acc SGD (CPF)","LU2063271972.USD":"富兰克林创新领域基金","LU2211814178.USD":"ALLIANZ CLEAN PLANET \"AT\" (USD) ACC","IE00BKVL7J92.USD":"Legg Mason ClearBridge - US Equity Sustainability Leaders A Acc USD","IE00BZ1G4Q59.USD":"LEGG MASON CLEARBRIDGE US EQUITY SUSTAINABILITY LEADER \"A\"(USD) INC (A)","LU2125910336.SGD":"Natixis Thematics Water R/A SGD","LU2244417387.USD":"FIDELITY SUSTAINABLE US EQUITY \"A\" (USD) ACC","LU0175139822.USD":"AB FCP I Global Equity Blend A USD","LU2355687059.USD":"NORDEA 1 GLOBAL IMPACT  \"BP\" (USD) ACC","LU1923621640.USD":"Natixis Thematics Water R/A USD","SGXZ23171101.USD":"NIKKO AM SHENTON GLOBAL OPPORTUNITIES (USD) ACC","LU2023250504.SGD":"Allianz Thematica Cl AMg DIS H2-SGD","LU0320765059.SGD":"FTIF - Franklin US Opportunities A Acc SGD","LU0114720955.EUR":"SUSTAINABLE GLOBAL HEALTH CARE \"A\" INC","BK4581":"高盛持仓","LU1917777945.USD":"安联专题基金Cl AT Acc","LU2125909247.SGD":"Natixis Thematics Meta H-R/A SGD","LU0528227936.USD":"富达环球人口趋势基金A-ACC","BK4121":"生命科学工具和服务","LU0820561909.HKD":"ALLIANZ INCOME AND GROWTH \"AM\" (HKD) INC","LU0289961442.SGD":"SUSTAINABLE GLOBAL THEMATIC PORTFOLIO \"AX\" (SGD) ACC","LU1791710582.SGD":"Fidelity Global Demographics A-ACC-SGD (SGD/USD hedged)"},"translate_title":"Get in position! Medical equipment knows early-8/2","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"DHR":0.9,"A":0.9},"content_text":"企业投融资与合作方面Orchestra BioMed 获战略投资：Ligand 和美敦力共注入 7000 万美元。其中，Ligand 投资 3500 万美元换取其 AVIM 疗法和 Virtue SAB 未来销售额分级特许权使用费，另在股权私募投资 500 万美元；美敦力在股权私募投资 1000 万美元，另通过可转换为预付收入份额的担保次级本票投资 2000 万美元。双方同时扩大战略合作，推进 AVIM 疗法支持的无导线起搏器开发。Versa Vascular获 2730 万美元融资：由Santa Cruz Ventures 领投，用于推进经导管三尖瓣修复系统临床前研究及商业扩展，融资获 2 亿超额认购。普立蒙完成C 轮融资：获近3 亿元融资，由雅惠投资等参与，启峰资本任财务顾问。该公司专注医用高分子材料和生物组织工程，拥有相关技术平台及近 30 张 NMPA 注册证，产品覆盖多科室。企业人事与业务变动丹纳赫总法律顾问将离职：高级副总裁兼总法律顾问Brian W. Ellis 于 2025 年 8 月 25 日卸任总法律顾问，2026 年 2 月 28 日退休。Globus Medical 人事变动：原CEO Daniel Scavilla 离职并加入 Dentsply Sirona 任 CEO，Keith Pfeil 自 7 月 18 日起接任该公司总裁兼 CEO。安捷伦科技大中华区总经理任命：8 月 1 日起，杨挺接任孙大鹏任大中华区总经理，同时继续担任安捷伦副总裁兼大中华区业务总经理；孙大鹏将于 9 月退休。利和兴退出医械业务：深交所上市企业利和兴旗下唯一医疗器械子公司利和兴医疗器械（江门）有限公司已完成注销。企业动态与业绩方面Monogram Orthopaedics 更新收购信息：7 月 31 日通知股东，其投资者关系页面设有关于 Zimmer Biomet 拟议收购的常见问题解答，该收购首次宣布于 7 月 14 日。Hologic 第三季度业绩：2025 财年第三季度营收 10.24 亿美元，非公认会计准则每股收益 1.08 美元，均超预期，得益于关键业务改善及收购整合；虽在部分市场面临挑战，但对增长持乐观态度。企业上市动态中慧生物- B 招股：7 月 31 日至 8 月 5 日招股，预计 8 月 8 日在港交所挂牌。此前曾两次递表（2025 年 1 月递表失效后 7 月 24 日二次递表，2023 年 6 月申请上交所科创板后主动撤回）。▲文章来源：医疗器械创新网▲转载请标注以上来源声明：本文仅作信息传递之目的，仅供参考。本文不对投资及治疗构成任何建议，请谨慎甄别。如涉及作品内容、版权和其它问题，为保障双方权益，请与我们联系，我们将立即处理。如有平台转载本篇文章，须自行对该篇文章负责，医疗器械创新网不对转载引起的二次传播负责。","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2556984181","isCrawlerRequest":true}